- Report
- June 2026
- 56 Pages
Germany
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 70 Pages
South Korea
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 70 Pages
United States
From €1203EUR$1,350USD£1,041GBP
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 47 Pages
Thailand
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 70 Pages
Switzerland
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 70 Pages
Sweden
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 70 Pages
Spain
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 70 Pages
South Korea
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 70 Pages
Singapore
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 70 Pages
Russia
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 70 Pages
Netherlands
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 70 Pages
Japan
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 70 Pages
Italy
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 70 Pages
China
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 70 Pages
Brazil
From €1203EUR$1,350USD£1,041GBP
- Report
- June 2026
- 50 Pages
Global
From €2362EUR$2,650USD£2,043GBP
- Report
- November 2025
- 132 Pages
Global
From €847EUR$950USD£732GBP
- Report
- November 2025
- 132 Pages
Global
From €847EUR$950USD£732GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more